Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kavanagh

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Screening for complement system abnormalities in patients with atypical hemolytic uremic syndromeDavid Kavanagh, Anna Richards, Veronique Fremeaux-Bacchi, et al.
BMC Health Services Research|October 31, 2012
Study protocol: Screening and Treatment of Alcohol-Related Trauma (START) - a randomised controlled trialRama Jayaraj, Mahiban Thomas, David Kavanagh, et al.
Cell Cycle (Georgetown, Tex.)|June 28, 2008
New roles for the major human 3'-5' exonuclease TREX1 in human diseaseDavid Kavanagh, Dirk Spitzer, Parul H Kothari, et al.
Ophthalmology Science|June 13, 2022
Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian RandomizationAmy V Jones, Stuart MacGregor, Xikun Han, et al.
Translational Vision Science & Technology|September 10, 2020
Functional Analysis of Rare Genetic Variants in Complement Factor I (<i>CFI</i>) using a Serum-Based Assay in Advanced Age-related Macular DegenerationAnuja Java, Peter Baciu, Rafael Widjajahakim, et al.
The Australian Journal of Rural Health|April 20, 2007
Challenges faced by general practitioners and allied mental health services in providing mental health services in rural QueenslandMatthew Bambling, David Kavanagh, Gisela Lewis, et al.
Acta Crystallographica. Section D, Biological Crystallography|June 24, 2011
Crystallographic determination of the disease-associated T1184R variant of complement regulator factor HHugh P Morgan, Jingzi Jiang, Andrew P Herbert, et al.
The New England Journal of Medicine|March 28, 2014
Thrombotic microangiopathy associated with interferon betaDavid Hunt, David Kavanagh, Iain Drummond, et al.
The Australian and New Zealand Journal of Psychiatry|September 7, 2010
Psychometric validation of the Growth and Empowerment Measure (GEM) applied with Indigenous AustraliansMelissa R Haswell, David Kavanagh, Komla Tsey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2020
Complement factor I deficiency: A potentially treatable cause of fulminant cerebral inflammationTom Altmann, Megan Torvell, Stephen Owens, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Screening for complement system abnormalities in patients with atypical hemolytic uremic syndromeDavid Kavanagh, Anna Richards, Veronique Fremeaux-Bacchi, et al.
BMC Health Services Research|October 31, 2012
Study protocol: Screening and Treatment of Alcohol-Related Trauma (START) - a randomised controlled trialRama Jayaraj, Mahiban Thomas, David Kavanagh, et al.
Cell Cycle (Georgetown, Tex.)|June 28, 2008
New roles for the major human 3'-5' exonuclease TREX1 in human diseaseDavid Kavanagh, Dirk Spitzer, Parul H Kothari, et al.
Ophthalmology Science|June 13, 2022
Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian RandomizationAmy V Jones, Stuart MacGregor, Xikun Han, et al.
Translational Vision Science & Technology|September 10, 2020
Functional Analysis of Rare Genetic Variants in Complement Factor I (<i>CFI</i>) using a Serum-Based Assay in Advanced Age-related Macular DegenerationAnuja Java, Peter Baciu, Rafael Widjajahakim, et al.
The Australian Journal of Rural Health|April 20, 2007
Challenges faced by general practitioners and allied mental health services in providing mental health services in rural QueenslandMatthew Bambling, David Kavanagh, Gisela Lewis, et al.
Acta Crystallographica. Section D, Biological Crystallography|June 24, 2011
Crystallographic determination of the disease-associated T1184R variant of complement regulator factor HHugh P Morgan, Jingzi Jiang, Andrew P Herbert, et al.
The New England Journal of Medicine|March 28, 2014
Thrombotic microangiopathy associated with interferon betaDavid Hunt, David Kavanagh, Iain Drummond, et al.
The Australian and New Zealand Journal of Psychiatry|September 7, 2010
Psychometric validation of the Growth and Empowerment Measure (GEM) applied with Indigenous AustraliansMelissa R Haswell, David Kavanagh, Komla Tsey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2020
Complement factor I deficiency: A potentially treatable cause of fulminant cerebral inflammationTom Altmann, Megan Torvell, Stephen Owens, et al.
Pageof 20